Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 22482-74-2 | MDL No. : | MFCD19370530 |
Formula : | C9H7ClO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HARZEJOUACLTDB-UHFFFAOYSA-N |
M.W : | 214.60 | Pubchem ID : | 66884655 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.11 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 49.96 |
TPSA : | 74.6 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.52 cm/s |
Log Po/w (iLOGP) : | 0.8 |
Log Po/w (XLOGP3) : | 1.54 |
Log Po/w (WLOGP) : | 1.67 |
Log Po/w (MLOGP) : | 1.82 |
Log Po/w (SILICOS-IT) : | 1.62 |
Consensus Log Po/w : | 1.49 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.85 |
Log S (ESOL) : | -2.26 |
Solubility : | 1.18 mg/ml ; 0.0055 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.72 |
Solubility : | 0.413 mg/ml ; 0.00192 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.17 |
Solubility : | 1.44 mg/ml ; 0.00671 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.88 |
Signal Word: | Warning | Class: | |
Precautionary Statements: | P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313 | UN#: | |
Hazard Statements: | H315-H319 | Packing Group: | |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 6 steps 1: Br2 3: NaOEt 4: H2SO4 6: (i) CrO3, (ii) aq. NaOH, (iii) aq. HCl |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
73% | at 180℃; for 64h; | A. A mixture of 2-CARBOXYMETHYL-3-CHLOROBENZOIC acid (1.91 g, 8.9 MMOL) and 2, 4-DIMETHYLBENZYLAMINE (1.35 mL, 9.6 MMOL) was placed in a vented vial and heated in an oil bath maintained at 180 C. After heating for 64 hours the reaction was allowed to cool to ambient temperature, then taken up in a mixture of CH2CI2, acetone, and methanol. The solution was mixed with silica gel and then concentrated under reduced pressure to afford a free flowing solid. This solid was loaded onto the top of a silica gel column and eluted with a gradient from 0% to 14% ethyl acetate/hexane to afford 5-CHLORO-2- (2, 4-DIMETHYLBENZYL)-4H-ISOQUINOLINE-1, 3-dione (2.03 g, 73 % yield) as a yellow solid : 1H-NMR (400 MHz, CDCI3) : 8 8.17 (1 H, dd, J = 7.8, 1.3 Hz), 7.65 (1 H, dd, J = 7.8, 1.3 Hz), 7.42 (1 H, app. t, J = 7.8 Hz), 6.98 (1 H, br s), 6.96-6. 92 (1H, m), 6.91-6. 87 (1H, m), 5.16 (2H, s), 4.09 (2H, s), 2.44 (3H, s), 2.26 (3H, s) ppm. |